Peptide stack builder: how peptide combinations are put together

What peptide stacking actually means

Stacking means combining two or more peptides that act on different biological pathways, on the theory that complementary mechanisms do more together than either does alone. The theory is reasonable and the mechanisms are real, but almost every popular combination has been studied only one compound at a time.

Peptide stacking is the practice of combining two or more peptides that target complementary biological pathways. The reasoning is straightforward: if one compound supports blood vessel formation and another supports cell migration, a tissue that needs both might respond better to both than to either alone. This is the core principle behind most of the protocols discussed in biohacking communities.

The most-cited example is the BPC-157 plus TB-500 combination, nicknamed the "wolverine stack." The individual mechanisms are documented: BPC-157 has been studied across a wide range of animal injury models, where its effects are attributed largely to vascular and growth-factor pathways [1], and in a rat and cell-culture tendon model it promoted tendon outgrowth, cell survival, and cell migration [2]. TB-500 is a synthetic fragment related to thymosin beta 4, an actin-binding peptide whose role in cell migration and dermal wound repair is well described [3].

What does not exist is a trial of the combination. Both halves of the wolverine stack rest on animal and in-vitro work, and no controlled human study has tested them together. That pattern repeats across nearly every stack you will see discussed online. Combining two compounds does not average their uncertainty, it compounds it: you inherit every open question about each one, plus a new set about how they interact. Treat every combination on this page as a description of what people talk about, not as a recommendation.

How the stack builder works

The builder takes four inputs: a primary goal, an optional secondary goal, an experience level, and a route preference. It returns the peptides most often discussed for that goal, each with an evidence tier, a mechanism-overlap score, timing context, complementary lifestyle practices, and the specific caveats that apply.

This free interactive tool lets you explore how peptide combinations are assembled, in four steps. Select your primary goal, an optional secondary goal, an experience level, and a preferred administration route. The builder then shows which compounds are commonly discussed for that combination of inputs, along with:

• Synergy score, a 0 to 100 estimate of how much the two mechanisms complement rather than duplicate each other. This is the builder's own heuristic, calculated from mechanism overlap. It is not a measured outcome and no study has ever reported it.
• Evidence tier, the highest quality of research available for that peptide's main claimed benefit, from human randomized trials down to anecdote.
• Timing context, why half-life and receptor kinetics are the reason sequencing gets discussed for a given pair at all. This is background on the pharmacology, not a schedule to follow.
• Complementary modalities, lifestyle practices such as cold exposure, red light, resistance training, and eating patterns that are studied for the same goal.
• Considerations, the contraindications, interaction concerns, and limitations attached to each compound.

The tool covers 10 of the more researched peptides across six goal categories: injury recovery, skin and anti-aging, sleep, longevity, fat loss and body composition, and cognition. If you are new to this, start with our peptide basics course first. For an honest look at what the research does and does not support, the peptide craze explained is a useful primer, and the peptide safety checker covers the documentation you should expect from any supplier before sourcing anything at all.

Popular community stacks

The combinations below are the ones discussed most often online. They are listed as examples of how people reason about mechanism overlap, with the evidence behind each individual compound stated plainly. Click any card to load it into the builder above and see the full breakdown.

These are the most commonly discussed peptide combinations in the biohacking community. Click any stack to load it into the builder above.

The growth hormone pairing, typically CJC-1295 with Ipamorelin, is the one combination class on this page with genuine human combination data behind the concept. A growth-hormone-releasing hormone analog and a growth-hormone-releasing peptide act on different receptors, and their co-administration produces a larger growth hormone response than either alone, a synergy that has been characterized directly in men [4]. The individual components are also documented in humans: CJC-1295 produced sustained increases in growth hormone and IGF-I in healthy adults [5], and Ipamorelin was characterized as a selective growth hormone secretagogue [6]. Note carefully what that does and does not establish. The class-level synergy is real; a specific outcome from a specific pairing in a specific person is not what those studies measured.

The longevity grouping usually names Epitalon, MOTS-c, and GHK-Cu together, on the logic that they target different hallmarks of aging. Each has a real mechanistic literature: Epitalon was reported to induce telomerase activity and telomere elongation in human somatic cells in culture [7], MOTS-c is a mitochondrial-derived peptide shown to improve metabolic homeostasis and insulin sensitivity in mice [8], and GHK-Cu has a large gene-expression literature covering tissue repair and regeneration [9]. None of that is a combination study, and the cell-culture and rodent settings involved are a long way from an outcome in a person.

The cognitive pairing of Semax with Selank is mostly a Russian-language literature, which makes it harder to appraise from the outside. Selank has been evaluated in a clinical setting for generalized anxiety disorder and neurasthenia [10], but much of the surrounding work sits in journals that are less accessible and less frequently replicated in Western trials. Our cognitive peptide explorer goes through that category compound by compound.

Understanding evidence tiers

Each peptide in the builder carries a tier badge showing the best available research for its main claimed benefit. The tiers run from human randomized trials down to anecdote. A low tier does not mean a compound does nothing, it means nobody has yet run the study that would tell you either way.

Each peptide in the builder displays an evidence tier badge. These indicate the highest quality of research available for that peptide's primary claimed benefits. For a deeper dive into how peptide evidence is evaluated, see our clinical evidence module.

• Human RCT, randomized controlled trials in humans, the gold standard.
• Human data, human observational studies, case reports, or approved use in other countries.
• Animal studies, effects demonstrated in animal models with limited human data.
• In-vitro, effects shown in cell cultures or lab settings only.
• Anecdotal, primarily self-reported community data.

A lower evidence tier does not mean a peptide is ineffective. It means the research is still catching up, and many compounds with strong animal data are in the pipeline for human trials. It also means the honest answer to "does this work" is often "nobody knows yet," which is a different claim from "it works, we just cannot prove it." When every compound in a proposed stack sits in the bottom three tiers, the stack has no evidence base at all, however confident the community discussion around it sounds.

Stack design principles

The smallest combination that addresses one clear goal is the easiest to interpret. When several compounds start at once, benefits and side effects become impossible to attribute, so if something goes wrong you cannot tell which input caused it. Foundational habits usually explain more of the outcome than another compound does.

The smallest stack that answers one clear goal is the easiest to interpret. Recovery, appetite control, sleep, injury support, and body composition are different targets. When several peptides are started at the same time, side effects and benefits become hard to attribute. If something goes wrong, you do not know which input caused it, and you have to unwind the whole thing to find out.

Start by separating foundational habits from experimental additions. Protein intake, resistance training, sleep timing, and injury load management often explain more of the outcome than another compound. A peptide stack should complement those levers, not hide that they are missing. If body composition and exercise performance are your area of interest, our muscle-building peptides guide covers the evidence tier for each compound in that category.

Why interaction risk is not only pharmacology

Interaction risk includes behavior, not just chemistry. A recovery compound can encourage someone to load an injured tissue before it is ready. Appetite suppression paired with low protein intake can worsen body composition even as scale weight falls. Stacked sleep interventions make daytime fatigue impossible to interpret.

Interaction risk includes behavior. Combining a recovery peptide with aggressive training can encourage someone to overload tissue before it is ready, and the perceived improvement is exactly what makes that dangerous. Combining appetite suppression with insufficient protein can make body composition worse even when scale weight drops. Combining multiple sleep or stress interventions can make daytime fatigue harder to interpret, because you have removed your own ability to tell which one is responsible.

For that reason, staged decisions beat simultaneous ones. Add one variable, define in advance what success should look like, track tolerability, and keep a written timeline. If the goal cannot be measured in a simple way, the plan is probably too vague to evaluate, and a vague plan plus several compounds is how people end up unable to explain what happened to them.

How to decide what not to stack

Redundancy is the easiest mistake to miss: two compounds aimed at the same pathway add uncertainty without adding benefit. Ask what unique job each one has, and if the answer is vague, simplify. Some goals need sequencing rather than stacking, because a cleaner sequence is easier to learn from.

Redundancy is one of the easiest mistakes to miss. Two compounds aimed at the same pathway can increase uncertainty without improving the outcome, and they can stack side effects while offering nothing additive. If both are supposed to improve recovery, appetite, sleep, or inflammation, ask what unique job each one has. If the answer is vague, simplify.

Sequencing matters too. Some goals need order more than they need combination. Injury support may come first, then progressive loading. Appetite considerations may come first, then muscle retention. Sleep regularity often has to be fixed before any recovery signal is interpretable at all. The cleaner the sequence, the easier it is to learn from the result.

This is also why named community stacks should be treated as examples, not templates. The same combination can mean different things depending on training load, diet, medication history, and the actual problem being solved. Context changes the stack and the risk. If exercise-mimic peptides like MOTS-c are part of what you are reading about, the exercise-mimic peptide explorer covers the metabolic and mitochondrial mechanisms behind that category in more depth.